Cargando…

Analysis of potential immune-related genes involved in the pathogenesis of ischemia-reperfusion injury following liver transplantation

BACKGROUND: Hepatic ischemia-reperfusion (I/R) injury is an unavoidable pathological process that occurs after liver transplantation. However, the immune-related molecular mechanism still remains unclear. This study aims to further explore the biological mechanisms of immune-related genes in hepatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jiayu, Han, Shangting, Chen, Qi, Wang, Tianyu, Yu, Bo, Zhou, Jiangqiao, Qiu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060527/ https://www.ncbi.nlm.nih.gov/pubmed/37006305 http://dx.doi.org/10.3389/fimmu.2023.1126497

Ejemplares similares

Ferroptosis—A New Dawn in the Treatment of Organ Ischemia–Reperfusion Injury
por: Zhou, Linxiang, et al.
Publicado: (2022)

Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination
por: Chen, Zhongbao, et al.
Publicado: (2023)

Hepatocellular SETDB1 Regulates Hepatic Ischemia-Reperfusion Injury through Targeting Lysine Methylation of ASK1 Signal
por: Xia, Kang, et al.
Publicado: (2023)

Dendritic Cell-Mediated Regulation of Liver Ischemia-Reperfusion Injury and Liver Transplant Rejection
por: Nakano, Ryosuke, et al.
Publicado: (2021)

Effect of Hepatic Macrophage Polarization and Apoptosis on Liver Ischemia and Reperfusion Injury During Liver Transplantation
por: Ye, Liping, et al.
Publicado: (2020)

Ubiquitin-Specific Peptidase 10 Protects Against Hepatic Ischaemic/Reperfusion Injury via TAK1 Signalling
por: Jiangqiao, Zhou, et al.
Publicado: (2020)

MAPK Signaling Pathways in Hepatic Ischemia/Reperfusion Injury
por: Yu, Bo, et al.
Publicado: (2023)

The Evolving Role of Neutrophils in Liver Transplant Ischemia-Reperfusion Injury
por: Nakamura, Kojiro, et al.
Publicado: (2019)

Endogenous Interleukin-33 Acts as an Alarmin in Liver Ischemia-Reperfusion and Is Associated With Injury After Human Liver Transplantation
por: Barbier, Louise, et al.
Publicado: (2021)

TFNR2 in Ischemia-Reperfusion Injury, Rejection, and Tolerance in Transplantation
por: Kouyoumdjian, Araz, et al.
Publicado: (2022)

Editorial: The role of immune cells in hepatic ischemia reperfusion
por: Ke, Bibo, et al.
Publicado: (2022)

Role of hepatic stellate cells in liver ischemia-reperfusion injury
por: Peng, Yuming, et al.
Publicado: (2022)

Expression analysis of long non-coding RNAs in a renal ischemia-reperfusion injury model
por: Tao, Qiu, et al.
Publicado: (2019)

Integrated Analysis of Prognostic Genes Associated With Ischemia–Reperfusion Injury in Renal Transplantation
por: Zhang, Di, et al.
Publicado: (2021)

Hypothermic machine perfusion alleviates ischemia-reperfusion injury of intestinal transplantation in pigs
por: Hou, Wen, et al.
Publicado: (2023)

Ischemia/Reperfusion Injury in Liver Surgery and Transplantation
por: Schemmer, Peter, et al.
Publicado: (2012)

Cellular Stress Response and Immune Signaling in Retinal Ischemia–Reperfusion Injury
por: Minhas, Gillipsie, et al.
Publicado: (2016)

Minimizing Ischemia Reperfusion Injury in Xenotransplantation
por: Patel, Parth M., et al.
Publicado: (2021)

Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for ex vivo delivery
por: Delaura, Isabel F., et al.
Publicado: (2022)

Liraglutide Attenuates Hepatic Ischemia–Reperfusion Injury by Modulating Macrophage Polarization
por: Li, Shang-Lin, et al.
Publicado: (2022)

Platelet Contributions to Myocardial Ischemia/Reperfusion Injury
por: Schanze, Nancy, et al.
Publicado: (2019)

Platelets as Modulators of Cerebral Ischemia/Reperfusion Injury
por: Stegner, David, et al.
Publicado: (2019)

NLRP3: Role in ischemia/reperfusion injuries
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

The role of extracellular traps in ischemia reperfusion injury
por: Zhang, Feilong, et al.
Publicado: (2022)

Dynamics of necroptosis in kidney ischemia-reperfusion injury
por: Pefanis, Aspasia, et al.
Publicado: (2023)

Ischemia/Reperfusion Injury in Liver Surgery and Transplantation: Pathophysiology
por: Weigand, Kilian, et al.
Publicado: (2012)

Abrogation of graft ischemia‐reperfusion injury in ischemia‐free liver transplantation
por: Guo, Zhiyong, et al.
Publicado: (2022)

Substance P Improves Renal Ischemia Reperfusion Injury Through Modulating Immune Response
por: Kim, Dong-Jin, et al.
Publicado: (2020)

Divergent roles of PD-L1 in immune regulation during ischemia–reperfusion injury
por: Luo, Jianheng, et al.
Publicado: (2022)

The Role of NLRP3 Inflammasome Activation Pathway of Hepatic Macrophages in Liver Ischemia–Reperfusion Injury
por: Wu, Tong, et al.
Publicado: (2022)

Properdin inhibition ameliorates hepatic ischemia/reperfusion injury without interfering with liver regeneration in mice
por: Kusakabe, Jiro, et al.
Publicado: (2023)

cGAS–STING pathway in ischemia-reperfusion injury: a potential target to improve transplantation outcomes
por: Chen, Zijian, et al.
Publicado: (2023)

Mesenchymal stromal cells in renal ischemia/reperfusion injury
por: de Vries, Dorottya K., et al.
Publicado: (2012)

Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury
por: Huang, Miao, et al.
Publicado: (2022)

Characterization of early myocardial inflammation in ischemia-reperfusion injury
por: Wu, Qihong, et al.
Publicado: (2023)

The Pathogenesis of Ischemia-Reperfusion Induced Acute Kidney Injury Depends on Renal Neutrophil Recruitment Whereas Sepsis-Induced AKI Does Not
por: Li, Zhenhan, et al.
Publicado: (2022)

Ischemia–Reperfusion Injury and Immunosuppressants Promote Polyomavirus Replication Through Common Molecular Mechanisms
por: Chen, Xu-Tao, et al.
Publicado: (2022)

Gene signature and prediction model of the mitophagy-associated immune microenvironment in renal ischemia-reperfusion injury
por: Chen, Ruo-Yang, et al.
Publicado: (2023)

Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell Death
por: Tang, Shen-ping, et al.
Publicado: (2022)

Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers
por: Kang, Jiman, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_14akm6o9t1c28bmbtbnu0hpa16